GE Healthcare Technologies Inc

More Details of GE Healthcare Technologies Inc Company

GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.

Company Info

Company codeGEHC

Company nameGE Healthcare Technologies Inc

IPO dateDec 15, 2022

Founded at2022

CEOMr. Kevin Michael O'Neill

Number of employees53000

Security typeOrdinary Share

Fiscal year-endDec 15

Address500 West Monroe Street

CityCHICAGO

Stock exchangeNASDAQ Global Select Consolidated

CountryUnited States of America

Postal code60661

Phone18337351139

Websitehttps://www.gehealthcare.com

Company codeGEHC

IPO dateDec 15, 2022

Founded at2022

Company Executives

Name

Name/Position

Position

Shareholding

Change

Mr. Peter J. Arduini

President, Chief Executive Officer, Director

283.15K

+160.52%

Mr. Roland Rott

President and CEO - Imaging

66.05K

+1.93K%

Mr. Kenneth Robert (Ken) Stacherski

Chief Global Supply Chain and Service Officer

31.67K

+19.01%

Mr. William J. Stromberg

Independent Director

9.20K

--

Ms. Anne T. Madden

Independent Director

8.76K

--

Dr. Rodney F. Hochman

Independent Director

8.76K

--

Dr. Risa J. Lavizzo-Mourey, M.D.

Lead Independent Director

7.07K

--

Dr. Tomislav Mihaljevic, M.D.

Independent Director

6.02K

--

Mr. Kevin Michael O'Neill

Chief Executive Officer - Pharmaceutical Diagnostics

165.00

-86.19%

Mr. Lloyd W. Howell, Jr.

Independent Director

--

Name

Name/Position

Position

Shareholding

Change

Mr. Peter J. Arduini

President, Chief Executive Officer, Director

283.15K

+160.52%

Mr. Roland Rott

President and CEO - Imaging

66.05K

+1.93K%

Mr. Kenneth Robert (Ken) Stacherski

Chief Global Supply Chain and Service Officer

31.67K

+19.01%

Mr. William J. Stromberg

Independent Director

9.20K

--

Ms. Anne T. Madden

Independent Director

8.76K

--

Dr. Rodney F. Hochman

Independent Director

8.76K

--

Revenue Breakdown

Currency: USDUpdate time: Sun, Apr 6

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q1

FY2021

FY2020

FY2019

By BusinessUSD

Name

Revenue

Proportion

Total Imaging

8.86B

45.01%

Total Ultrasound

5.13B

26.08%

Total PCS

3.13B

15.89%

Total PDx

2.51B

12.75%

Other

52.00M

0.26%

By RegionUSD

Name

Revenue

Proportion

Other

8.92B

45.34%

United States

8.62B

43.80%

China

2.13B

10.85%

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Total Imaging

8.86B

45.01%

Total Ultrasound

5.13B

26.08%

Total PCS

3.13B

15.89%

Total PDx

2.51B

12.75%

Other

52.00M

0.26%

Shareholder

Update time: Fri, Feb 21

Shareholder Statistics

Type

Shareholder Statistics

Shareholder

Proportion

Capital Research Global Investors

13.29%

The Vanguard Group, Inc.

11.43%

BlackRock Institutional Trust Company, N.A.

5.43%

State Street Global Advisors (US)

4.13%

Dodge & Cox

3.64%

Other

62.08%

Shareholder Statistics

Shareholder

Proportion

Capital Research Global Investors

13.29%

The Vanguard Group, Inc.

11.43%

BlackRock Institutional Trust Company, N.A.

5.43%

State Street Global Advisors (US)

4.13%

Dodge & Cox

3.64%

Other

62.08%

Type

Shareholder

Proportion

Investment Advisor

40.35%

Investment Advisor/Hedge Fund

36.91%

Hedge Fund

3.13%

Research Firm

2.52%

Pension Fund

2.22%

Sovereign Wealth Fund

1.44%

Bank and Trust

1.32%

Insurance Company

0.36%

Individual Investor

0.27%

Other

11.47%

Institutional Shareholding

Update time: Sun, Jan 19

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q1

2333

405.87M

88.75%

-9.18M

2024Q4

2344

405.16M

88.60%

-9.34M

2024Q3

2188

396.50M

86.79%

-11.03M

2024Q2

2081

391.61M

85.76%

-10.20M

2024Q1

2000

385.11M

84.39%

-2.29M

2023Q4

1855

385.99M

84.77%

-4.81M

2023Q3

1708

381.18M

83.73%

+1.51M

2023Q2

1574

374.50M

82.34%

-3.85M

2023Q1

1358

378.91M

83.35%

+182.70M

2022Q4

41

468.43M

103.20%

+468.43M

Shareholder Activity

Name

Shares Held

Proportion

Change

Chg %

Date

Capital Research Global Investors

60.83M

13.3%

+2.61M

+4.48%

Dec 31, 2024

The Vanguard Group, Inc.

52.34M

11.45%

+2.16M

+4.30%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

24.86M

5.44%

+239.16K

+0.97%

Dec 31, 2024

State Street Global Advisors (US)

18.90M

4.13%

+281.45K

+1.51%

Dec 31, 2024

Dodge & Cox

16.68M

3.65%

+11.87K

+0.07%

Dec 31, 2024

Geode Capital Management, L.L.C.

11.32M

2.48%

+342.82K

+3.12%

Dec 31, 2024

Invesco Capital Management (QQQ Trust)

9.45M

2.07%

+126.88K

+1.36%

Feb 28, 2025

Norges Bank Investment Management (NBIM)

6.25M

1.37%

+1.84M

+41.76%

Dec 31, 2024

AllianceBernstein L.P.

6.13M

1.34%

-220.13K

-3.47%

Dec 31, 2024

Hotchkis and Wiley Capital Management, LLC

5.58M

1.22%

-18.35K

-0.33%

Dec 31, 2024

Related ETFs

Update time: Sun, Apr 6

Name

Proportion

Langar Global HealthTech ETF

10.47%

Invesco S&P Spin-Off ETF

7.54%

Otter Creek Focus Strategy ETF

4.86%

Absolute Select Value ETF

4.37%

iShares U.S. Medical Devices ETF

3.93%

Capital Group Dividend Value ETF

2.81%

VanEck Morningstar Wide Moat Value ETF

2.69%

VanEck Morningstar Wide Moat ETF

2.38%

VanEck Morningstar Wide Moat Growth ETF

1.99%

Themes US R&D Champions ETF

1.97%

Langar Global HealthTech ETF

Proportion10.47%

Invesco S&P Spin-Off ETF

Proportion7.54%

Otter Creek Focus Strategy ETF

Proportion4.86%

Absolute Select Value ETF

Proportion4.37%

iShares U.S. Medical Devices ETF

Proportion3.93%

Capital Group Dividend Value ETF

Proportion2.81%

VanEck Morningstar Wide Moat Value ETF

Proportion2.69%

VanEck Morningstar Wide Moat ETF

Proportion2.38%

VanEck Morningstar Wide Moat Growth ETF

Proportion1.99%

Themes US R&D Champions ETF

Proportion1.97%

Dividend

A total of 96.00M USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

Nov 21, 2024

GEHC.NB Final Cash Dividend of gross USD 0.035 paid on Feb 14, 2025 going ex on Jan 14, 2025

Jan 14, 2025

Feb 14, 2025

Jan 14, 2025

Sep 18, 2024

GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Nov 15, 2024 going ex on Oct 18, 2024

Oct 18, 2024

Nov 15, 2024

Oct 18, 2024

Jun 26, 2024

GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 15, 2024 going ex on Jul 19, 2024

Jul 19, 2024

Aug 15, 2024

Jul 19, 2024

Mar 22, 2024

GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on May 15, 2024 going ex on Apr 18, 2024

Apr 19, 2024

May 15, 2024

Apr 18, 2024

Dec 08, 2023

GEHC.NB Final Cash Dividend of gross USD 0.03 paid on Feb 15, 2024 going ex on Jan 12, 2024

Jan 16, 2024

Feb 15, 2024

Jan 12, 2024

Sep 22, 2023

GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Nov 15, 2023 going ex on Oct 19, 2023

Oct 20, 2023

Nov 15, 2023

Oct 19, 2023

Jun 23, 2023

GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 15, 2023 going ex on Jul 20, 2023

Jul 21, 2023

Aug 15, 2023

Jul 20, 2023

Apr 25, 2023

GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Jun 15, 2023 going ex on May 22, 2023

May 23, 2023

Jun 15, 2023

May 22, 2023

Stock Split

Date

Type

Ratio

No Data

Date

Type

Ratio

No Data

68.090USD

GE Healthcare Technologies Inc

68.090

Overview

Company